YD Bio Limited Ordinary Shares (YDES) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - |
| Operating Expenses | 389.19K | 353.82K | 381.29K | 260.08K | 537.41K | 1.05M | 506.73K |
| OpEx % of Revenue | - | - | - | - | - | - | - |
| Selling, General & Admin | 389.19K | 353.82K | 381.29K | 260.08K | 537.41K | 1.05M | 506.73K |
| SG&A % of Revenue | - | - | - | - | - | - | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -389.19K | -353.82K | -381.29K | -260.08K | -537.41K | -1.05M | -506.73K |
| Operating Margin % | - | - | - | - | - | - | - |
| Operating Income Growth % | 27.58% | 66.21% | 24.75% | - | - | - | - |
| EBITDA | -2.22M | -3.37M | 417.79K | 2.18M | 17.11M | -22.01M | 676.42K |
| EBITDA Margin % | - | - | - | - | - | - | - |
| EBITDA Growth % | -112.95% | 84.71% | -38.23% | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -2.22M | -3.37M | 417.79K | 2.18M | 17.11M | -22.01M | 676.42K |
| Net Interest Income | 34.58K | 34.56K | 122.08K | 135.54K | 170.99K | 169.58K | 167.64K |
| Interest Income | 34.58K | 34.56K | 122.08K | 135.54K | 170.99K | 169.58K | 167.64K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | -1.83M | -3.01M | 799.08K | 2.44M | 17.65M | -20.96M | 1.18M |
| Pretax Income | -2.22M | -3.37M | 417.79K | 2.18M | 17.11M | -22.01M | 676.42K |
| Pretax Margin % | - | - | - | - | - | - | - |
| Income Tax | -1.68K | 1.75K | 0 | -12.04K | 6.26K | 5.78K | -15.63K |
| Effective Tax Rate % | 0.08% | -0.05% | 0% | -0.55% | 0.04% | -0.03% | -2.31% |
| Net Income | -2.21M | -3.37M | 417.79K | 2.19M | 17.1M | -22.02M | 692.04K |
| Net Margin % | - | - | - | - | - | - | - |
| Net Income Growth % | -112.95% | 84.7% | -39.63% | - | - | - | - |
| Net Income (Continuing) | -2.21M | -3.37M | 417.79K | 2.19M | 17.1M | -22.02M | 692.04K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.65 | -0.98 | 0.10 | 0.54 | 4.05 | -5.12 | 0.16 |
| EPS Growth % | -116.05% | 80.86% | -37.5% | - | - | - | - |
| EPS (Basic) | -0.65 | -0.98 | 0.10 | 0.54 | 4.05 | -5.12 | 0.16 |
| Diluted Shares Outstanding | 3.41M | 3.42M | 4.03M | 4.03M | 4.22M | 4.3M | 4.3M |
| Basic Shares Outstanding | 3.41M | 3.42M | 4.03M | 4.03M | 4.22M | 4.3M | 4.3M |
| Dividend Payout Ratio | - | - | - | - | - | - | - |